STOCK TITAN

Lantheus to Present at the Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Lantheus Holdings (NASDAQ: LNTH) announced that Mary Anne Heino, CEO, and Bob Marshall, CFO, will present at the Jefferies Healthcare Conference on June 9 at 11:00 a.m. ET. The event will take place in New York City, showcasing the company's commitment to innovative imaging diagnostics and therapeutics. Investors can access a live webcast of the presentation on the company’s website, with a replay available for 30 days post-event. Lantheus is a leader in advanced medical imaging solutions, aiming to enhance patient care through its diverse product portfolio.

Positive
  • None.
Negative
  • None.

NORTH BILLERICA, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced Mary Anne Heino, President and Chief Executive Officer, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies Healthcare Conference at 11:00 a.m. ET on Thursday, June 9, in New York.

To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for 30 days following the live presentation.

About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; PYLARIFY®, a PSMA PET imaging agent for the detection of suspected recurrent or metastatic prostate cancer; PYLARIFY AI™, an artificial intelligence platform that assists in the evaluation of PSMA PET images; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Contacts:
Mark Kinarney
Senior Director, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Senior Director, Corporate Communications
646-975-2533
media@lantheus.com


FAQ

What will Lantheus Holdings discuss at the Jefferies Healthcare Conference on June 9, 2022?

Lantheus Holdings will discuss their innovative imaging diagnostics and therapeutics at the Jefferies Healthcare Conference.

Who will represent Lantheus Holdings at the Jefferies Healthcare Conference?

Mary Anne Heino, President and CEO, and Bob Marshall, CFO, will represent Lantheus Holdings.

Where can I watch the Lantheus Holdings presentation live?

You can watch the Lantheus Holdings presentation live on their website in the Investors section.

When will the Lantheus Holdings presentation take place at the Jefferies Healthcare Conference?

The presentation will take place on June 9, 2022, at 11:00 a.m. ET.

How long will the webcast of Lantheus Holdings' presentation be available for replay?

The replay of Lantheus Holdings' presentation will be available for 30 days after the live event.

Lantheus Holdings, Inc

NASDAQ:LNTH

LNTH Rankings

LNTH Latest News

LNTH Stock Data

6.28B
67.75M
2.47%
106.95%
6.41%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
NORTH BILLERICA